DORAL, Florida, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (ETST) (âETST" or the âCompany"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that it has entered into agreements with CannaBiz and Dessert Sun Distribution to distribute the Companyâs High Grade Full Spectrum Cannabinoids line throughout pharmacies, chiropractors, dispensaries, athletic clubs and clinics in the United States.
The agreements fall under broader strategies implemented by ETST Chief Sales Officer David Burbash, who is expanding the Companyâs sales team to explore product placement in large chains, health food stores and other establishments.
âWe see tremendous synergy between our CBD line and the healthcare practitioner and pharmacy spaces,â says ETST Chief Sales Officer David Burbash. âThe distribution agreements with CannaBiz and Dessert Sun Distribution, while important, are only a fraction of the opportunities we see for our CBD products.â
ETST is also taking steps to gain insular protection and loyalty in the competitive cannabis market. The Company has collaborated with its manufacturing partner to launch a white labeling initiative that will enable other marketers to rebrand the Companyâs High Grade Full Spectrum Cannabinoids line.
âIâm excited to share that our sales during the past three quarters have consistently increased over 100% every month. We have also received countless white labeling inquires, and thanks to our reliable source and manufacturer, we are now able to fulfill these inquires and capture even more market share,â says ETST Chairman Nickolas S. Tabraue. âWe have a lot of opportunity on deck for 2019, and we look forward to sharing the results of our strategies, which include our Latin American distribution partnership and upcoming High Grade Full Spectrum Iq2 Cannabinoids shot.â
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (âETSTâ) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Companyâs CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors:
Earth Science Pharmaceutical,
Inc.
Earth Science Pharmaceutical ("ESP") is a wholly-owned subsidiary
of Earth Science Tech, committed to the development of low cost,
non-invasive diagnostic tools, medical devices, testing processes
and vaccines for sexually transmitted infections and/or diseases.
ESP's CEO and chief science officer, Dr. Michel Aubé, is
leading the Companyâs research and development efforts. The
Companyâs first medical device, Hygeeâ¢, is a home kit designed for
the detection of STIs, such as chlamydia, from a self-obtained
gynecological specimen. ESP is working to develop and bring to
market medical devices and vaccines that meet the specific needs of
women. To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics,
Inc.
Cannabis Therapeutics (âCTIâ) is a wholly-owned subsidiary of Earth
Science Tech, Inc. poised to take a leadership role in the
development of new, leading-edge cannabinoid-based pharmaceutical
and nutraceutical products. CTI is invested in research and
development to explore and harness the medicinal power of
cannabidiol. The company holds three provisional application
patents for a CBD product that is focused on developing treatments
for breast and ovarian cancers, as well as two generic CBD based
pharmaceutical drugs. To learn more please visit: www.CannabisThera.com
KannaBidioiD, Inc.
KannaBidioiD (âKBDâ) is a wholly-owned subsidiary of Earth Science
Tech, Inc. that provides a wide variety of products geared toward
the recreational space of cannabis. KBDâs unique Kanna and CBD
formulation is sold and distributed in CBD-infused vapes/e-liquids
products. Kanna and CBD synergistically enhance one another,
providing optimal relaxation, an uplifting sensation, enhanced
focus and the added benefit of assisting with nicotine reduction
therapy. To learn more please visit: www.KannaBidioiDInc.com
Earth Science Foundation,
Inc.
Earth Science Foundation (âESFâ) is a wholly-owned subsidiary of
Earth Science Tech, Inc. ESF is in the process of becoming a
non-profit organization to accept grants and donations to conduct
further studies and help donate Earth Science Tech's effective CBD
products to those in need. To learn more please
visit: www.ETSTFoundtion.org
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact:
www.EarthScienceTech.com
Nickolas S. Tabraue
President, Director & Chairman
305.615.2118 Office
Corporate Communications
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]